[ Price : $8.95]
FDA issues guidances with recommended best practices to use in developing proprietary names for human prescription and non-prescri...[ Price : $8.95]
The ACLU says federal courts should continue to block an FDA policy requiring patients seeking mifepristone to appear in person at...[ Price : $8.95]
FDA says the Oncology Center of Excellences Project Orbis received 60 applications in its first full year of existence and approve...[ Price : $8.95]
FDA grants Turning Point Therapeutics a breakthrough therapy designation for repotrectinib and its use in treating certain patient...[ Price : $8.95]
FDA releases its latest batch of Warning Letters that include Natures Boost and Valentus.[ Price : $8.95]
Federal Register notice: FDA announces that Y-mAbs Therapeutics was awarded a priority review voucher related to the approval of D...[ Price : $8.95]
FDA tests its capability to receive annotated electrocardiogram waveform data in electronic format under the Health Level Seven (H...[ Price : $8.95]
Former FDA Office of Compliance and Biologics Quality deputy director Mark I. Schwartz criticizes FDA for its slow response to the...